SIS
KRRO icon

Strategic Investment Solutions’s Korro Bio KRRO Stock Holding History

Strategic Investment Solutions’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10
Closed -$95 – 679
2024
Q2 		$95 Buy
+10
New +$553 ﹤0.01% 592

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Strategic Investment Solutions's KRRO Position: Q3 2024 in Review

Strategic Investment Solutions sold out of Korro Bio (KRRO) in Q3 2024, closing a stake of 10 shares — an estimated $95 sold.

Strategic Investment Solutions first reported a position in KRRO in Q2 2024 and held it in 1 quarter. The position peaked at $95 in Q2 2024. 71 funds tracked by Wall St. Rank hold KRRO as of Q3 2024.

  • Strategic Investment Solutions reported no remaining Korro Bio position as of Q3 2024 after selling out during the quarter.
  • Strategic Investment Solutions sold 10 Korro Bio shares in Q3 2024, an estimated $95.
  • Strategic Investment Solutions first reported a position in Korro Bio in Q2 2024 and held it in 1 quarter.
  • Strategic Investment Solutions's Korro Bio position peaked at $95 in Q2 2024.
  • 71 funds tracked by Wall St. Rank held Korro Bio as of Q3 2024.

Based on Strategic Investment Solutions's 13F filing for Q3 2024, filed 23 Oct 2024.